Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside
|
|
|
|
چکیده: (10245 مشاهده) |
Immunotherapy has been used for years in many types of cancer therapy. Recently, cancer immunotherapy has focused on mechanisms which can enhance the development of cell-mediated immunity. Anticancer medications are administered to inhibit immunosuppressive factors such as nagalase enzyme, which is produced by neoplastic cells and destroys macrophage activating factor (Gc-MAF). Anti-neoplastics medications can also enhance immune-cell activity against tumors. Such medications show great potential in cancer immunotherapy using natural human mechanisms against neoplasms. |
|
|
|
متن کامل [PDF 548 kb]
(2109 دریافت)
|
نوع مطالعه: Review Article |
موضوع مقاله:
Oncology دریافت: 1395/6/1 | پذیرش: 1395/12/16 | انتشار: 1396/5/7
|
|
|
|
|
ارسال نظر درباره این مقاله |
|
|